Global Neutral Borosilicate Glass Injection Vial Market Growth 2023-2029

Global Neutral Borosilicate Glass Injection Vial Market Growth 2023-2029

The global Neutral Borosilicate Glass Injection Vial market size is projected to grow from US$ 1424.4 million in 2022 to US$ 2816.3 million in 2029; it is expected to grow at a CAGR of 10.2% from 2023 to 2029.

At present, the world's neutral borosilicate glass is mainly supplied by SCHOTT of Germany, NEG of Nippon Electric Glass, CORNING of the United States and Nipro, which are expensive. International pharmaceutical companies generally choose medium borosilicate glass as the material for injection bottles. Injection bottles made of neutral borosilicate glass have incomparable advantages over injection bottles made of ordinary soda lime glass and low borosilicate glass. With the maturity of the production process of neutral borosilicate glass and the entry of new market players, the market size of injection bottles is expected to continue to grow.

Neutral borosilicate glass: The average linear thermal expansion coefficient of medium borosilicate glass is: α=(4-5)×10-6/°C (20-300°C), referred to as 5.0 glass, invented and started production by Schott in Germany in 1889 ( It was named Fiolax at that time), and its composition was SiO266%, B2O37%, Al2O310%, CaO6%, Na2O8%, K2O3%. According to the modern classification standard of B2O3 content, the original Fiolax can only be counted as low borosilicate glass. In 1943, Kimble in the United States invented medium borosilicate glass with a B2O3 content greater than 8%, and then Germany, Japan and other countries successively produced this medium borosilicate glass. This type of glass is widely used in the field of pharmaceutical packaging due to its good material and performance, especially its excellent chemical stability. Neutral borosilicate glass is far superior to low borosilicate glass in terms of water resistance, acid and alkali resistance, freezing resistance, thermal stability, filling speed, etc. There will be no sedimentation in long-term contact with liquid medicine and blood. Injection vials made of neutral borosilicate glass offer additional advantages.

LPI (LP Information)' newest research report, the “Neutral Borosilicate Glass Injection Vial Industry Forecast” looks at past sales and reviews total world Neutral Borosilicate Glass Injection Vial sales in 2022, providing a comprehensive analysis by region and market sector of projected Neutral Borosilicate Glass Injection Vial sales for 2023 through 2029. With Neutral Borosilicate Glass Injection Vial sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neutral Borosilicate Glass Injection Vial industry.

This Insight Report provides a comprehensive analysis of the global Neutral Borosilicate Glass Injection Vial landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neutral Borosilicate Glass Injection Vial portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Neutral Borosilicate Glass Injection Vial market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neutral Borosilicate Glass Injection Vial and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neutral Borosilicate Glass Injection Vial.

This report presents a comprehensive overview, market shares, and growth opportunities of Neutral Borosilicate Glass Injection Vial market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Controlled Injection Vials
Molded Injection Vials

Segmentation by application
Medicine
Vaccine

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
SCHOTT
Cangzhou Four Stars Glass
Chongqing Zhengchuan Pharmaceutical Packaging
Shandong Pharmaceutical Glass
Nipro
Chengdu Jingu Pharma-Pack
Gerresheimer Shuangfeng
Linuo
Wuhu Changjiang Glass Products
Anhui Huaxin Pharmaceutical Glass Products
SGD Pharma
Famacy Group
JOTOP GLASS

Key Questions Addressed in this Report

What is the 10-year outlook for the global Neutral Borosilicate Glass Injection Vial market?

What factors are driving Neutral Borosilicate Glass Injection Vial market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Neutral Borosilicate Glass Injection Vial market opportunities vary by end market size?

How does Neutral Borosilicate Glass Injection Vial break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.